Please login to the form below

Not currently logged in
Email:
Password:

insulin

This page shows the latest insulin news and features for those working in and with pharma, biotech and healthcare.

FDA adcomm split on Sanofi’s type 1 diabetes drug

FDA adcomm split on Sanofi’s type 1 diabetes drug

The panel voted eight to eight when asked if the overall benefits of Zynquista (sotagliflozin) outweighed its risks as an add-on to insulin treatment for adult patients with type 1 ... It is also a key element in Sanofi’s plans to rebuild its diabetes

Latest news

  • Merck’s backing of NGM Bio yields NASH drug deal Merck’s backing of NGM Bio yields NASH drug deal

    The mid-stage candidate, called NGM313, is an antibody targeting the beta-Klotho/FGFR1c receptor complex that Merck describes as a “once-monthly injectable insulin sensitizer” and could represent a whole ... Merck says NGM313 has potential in both

  • FDA takes aim at pharma’s biosimilar-delaying tactics FDA takes aim at pharma’s biosimilar-delaying tactics

    At the moment insulins are regulated in the same way as small molecule drugs. ... pathway – in fact there ae no approved insulin products that can be substituted at the pharmacy level in the US at the moment.

  • As France protests, Sanofi takes axe to 670 jobs As France protests, Sanofi takes axe to 670 jobs

    The cost-cutting comes as Sanofi is trying to weather the effects of losing patent protection for diabetes blockbuster Lantus (insulin glargine) and build momentum behind new drugs such as atopic

  • Google boosts healthcare business with new hire Google boosts healthcare business with new hire

    Most recently, the company – with Sanofi in tow – has entered into a collaborative deal with Swiss tech group Sensile Medical to develop an all-in-one insulin patch pump for those

  • Novo Nordisk to launch connected insulin pens Novo Nordisk to launch connected insulin pens

    to make two durable, connected insulin pens NovoPen 6 and NovoPen Echo Plus commercially available across key markets from early 2019. ... Novo Nordisk will also integrate insulin-dosing data with Dexcom CGM data in the coming years.

More from news
Approximately 67 fully matching, plus 427 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 37 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics